Therefore, protracted PYY (3-36) analogs reduce body weight in rodents, and PYY analogs are currently being investigated for the treatment of obesity (Leitch et al., 2019). The gene discussed is PYY; the disease is obesity due to melanocortin 4 receptor deficiency.